Xiao, Qingquan

Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice

Zhou, H., Su, J., Hu, X., Zhou, C., Li, H., Chen, Z., Xiao, Q., Wang, B., Wu, W., Sun, Y., et al. (2020) · Cell

CRISPR and Genetic EngineeringRetinal Development and Disorders

Cited by 437

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

Xu, C., Zhou, Y., Xiao, Q., He, B., Geng, G., Wang, Z., Cao, B., Dong, X., Bai, W., Wang, Y., et al. (2021) · Nature Methods

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 351

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects

Tong, H., Huang, J., Xiao, Q., He, B., Dong, X., Liu, Y., Yang, X., Han, D., Wang, Z., Wang, X., et al. (2023) · Nature Biotechnology

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 230

Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor

Xiao, Q., Xu, Z., Xue, Y., Xu, C., Han, L., Liu, Y., Wang, F., Zhang, R., Han, S., Wang, X., et al. (2022) · Science Translational Medicine

CRISPR and Genetic EngineeringHearing, Cochlea, Tinnitus, Genetics

Cited by 95

Mini-dCas13X–mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy

Li, G., Jin, M., Li, Z., Xiao, Q., Lin, J., Yang, D., Liu, Y., Wang, X., Xie, L., Ying, W., et al. (2023) · Journal of Clinical Investigation

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 44